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Spinal-Z, a methanolic mixture of dried powdered seeds of Peganum harmala Linn. and leaf of Dracocephalum kotschyii Boiss. is
an Iranian ethno-medical remedy. It has been used for the treatment of various types of cancer for many years. To evaluate the use
of Spinal-Z in treatment of cancer, we examined its eﬀects against a panel of malignant cell lines and tumors induced in mice.
The in vitro antiproliferative activities of Spinal-Z, the seed extract of P. harmala and the leaf extract of D. kotschyii were deter-
mined using the MTT assay. The concentration of the agent required to inhibit cell growth by 50% (IC50) was estimated. In addition,
the anti-tumor activities of the remedy and its constituents were investigated.
Viability of cells treated with Spinal-Z and its components decreased in a dose dependent manner. Spinal-Z and its components
showed cytotoxic eﬀects against all cell lines tested. The leaf extract of D. kotschyii showed a greater preferential cytotoxic eﬀect than
the seed extract of P. harmala and Spinal-Z, on all cell lines tested. Harmine showed cytotoxicity against HL60 and K562 cell lines.
This could explain the cytotoxic eﬀect of P. harmala on these cells. The leaf extract of D. kotschyii was able to inhibit tumor pro-
liferation in mice. The active ingredient in the leaf extract of D. kotschyii appears to be a ﬂavone identiﬁed as xanthomicrol. Xant-
homicrol was able to inhibit proliferation of a number of malignant cells. The cytotoxic eﬀects of xanthomicrol were more selective
towards malignant cells than doxorubicin.
 2005 Elsevier Ltd. All rights reserved.
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Agents that preferentially inhibit proliferation of neo-
plastic cells may oﬀer means of developing drugs eﬀec-
tive against cancer in human. One of the strategies for
ﬁnding such agents is screening plant material, especially
those which have been reported to have anti-cancer,
anti-inﬂammatory, anti-fungal or anti-bacterial eﬀects0031-9422/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.phytochem.2005.04.035
* Corresponding author. Tel.: +98 21 805 8696; fax: +98 21 805 8696/
8719.
E-mail address: masmah99@iums.ac.ir (M. Mahmoudian).(Cordell et al, 1991; Cox and Balick, 1994; Wu et al.,
2002). Spinal-Z, is a traditional Iranian anticancer rem-
edy (Sobhani et al., 2002). It was used by traditional
healers as a plant concoction for the treatment of many
forms of cancer in humans. These traditional healers be-
lieved that the concoction was especially eﬀective against
leukemia and GI tract malignancy. Spinal-Z is an ex-
tract consisting of two plants: Peganum harmala Linn.
seeds and Dracocephalum kotschyii Boiss leaves
(80:20% w/w) (Sobhani et al., 2002). P. harmala, a mem-
ber of the family Zygophyllaceae, is a poisonous
plant that is native to Iran (Sobhani et al., 2002). Many
diﬀerent pharmacological eﬀects have been attributed to
Table 1
The cytotoxic eﬀect of Spinal-Z, Peganum harmala seed extract and
Dracocephalum kotschyii leaf extract against a panel of human cell
lines
Cell
line
Dracocephalum
kotschyii
Peganum
harmala
Spinal-Z
A172 6.8 ± 0.9 27.1 ± 1.0 NM
A2780-s 7.5 ± 1.0 26.4 ± 1.1 36.1 ± 1.0
HL60 16.3 ± 1.0 24.5 ± 1.0 66.7 ± 1.0
KB 18.1 ± 1.2 174.4 ± 1.3 441.2 ± 2.3
K562 26.9 ± 3.2 19.4 ± 1.4 64.7 ± 1.95
MCF-7 41.7 ± 3.9 70.1 ± 1.0 162.3 ± 2.2
Saos-2 51.8 ± 1.1 84.4 ± 1.5 80.6 ± 1.3
Hela 57.7 ± 0.9 59.1 ± 1.0 106.1 ± 2.1
A2780-cp 78.1 ± 3.7 60.8 ± 1.9 129.4 ± 1.7
A549 87.8 ± 1.7 NM NM
A375 100.3 ± 1.5 NM NM
HFFF-P16 331 ± 1.2 182.9 ± 1.2 444 ± 2.3
IC50 value was calculated by measuring cell proliferation using the
MTT assay and is deﬁned as the drug concentration (lg/mL) causing a
50% inhibition of cell growth.
Data represent mean values ± SD for three independent experiments.
NM: not measured.
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fects of P. harmala may be attributed to its b-carboline
alkaloid content, mainly harmine and harmaline. These
alkaloids are both monoamine oxidase inhibitors (Kim
et al., 1997) and spasmolytic (Shi et al., 2001). Harmine
the major b-carboline alkaloid in P. harmala extract is a
DNA topoisomerase type I inhibitor (Sobhani et al.,
2002), speciﬁc cyclin-dependent kinases inhibitor (Song
et al., 2004), antileishmania (Di Giorgio et al., 2004),
genotoxic (Boeira et al., 2001, 2002) and recombino-
genic (Boeira et al., 2002) agent. It has shown cytotoxic
activity against a series of tumor cell lines (Lamchouri
et al., 2000). Although a large number of studies on the
pharmacological eﬀects of P. harmala and its compo-
nents have been reported (Beutler et al., 1993; Lamcho-
uri et al., 1999; Mahmoudian et al., 2002), there is little
information available on the pharmacological eﬀects of
the leaf extract of D. kotschyii. D. kotschyii, a member
of Labiatae family, is a native Iranian plant (Ghahr-
eman, 1987). Its leaf extract has been reported to have
immunomodulatory (Amirghofran et al., 2000) and
antihyperlipidemic (Ebrahim Sajjadi et al., 1998) eﬀects.
In this study, the cytotoxic eﬀects of Spinal-Z are com-
pared with the eﬀects of its components, in particular
D. kotschyii, against a number of cell lines. Also, the
anti-tumor eﬀect of Spinal-Z and its constituents are
examined in mice inoculated with cancer cells. In addi-
tion an attempt is made to compare the in vitro and in
vivo eﬀect of these plant extracts with known anti-tumor
compounds: Doxorubicin and Camptothecin.2. Results
2.1. In vitro cytotoxicity tests
The cytotoxicity of Spinal-Z, the leaf extract of D.
kotschyii, the seed extracts of P. harmala and its major
b-carboline alkaloid harmine were examined in several
human tumor cell lines (HL60, K562, Hela, KB, A549,
Saos-2, A2780-CP, A2780-S, MCF-7, A375 and A172).
HFFF-P16 cells were used as non-malignant control.
The IC50 values against each cell line are presented in
Table 1. Also, a cytotoxic index was calculated for each
agent as IC50 of test compound against HFFF-P16 di-
vided by its IC50 against cancer cell line (Fig. 1). This
cytotoxic index could give an indication of the preferen-
tial eﬀects of the test compound on cancer cell lines com-
pared with non-malignant cells. In all the malignant cell
lines tested, Spinal-Z showed cytotoxic eﬀects (Table 1).
The cytotoxic indices for Spinal-Z against A2780-S,
HL60, K562 and Saos-2 cells suggested that this remedy
had preferential cytotoxicity against these cell lines (Fig.
1). Of all three agents used D. kotschyii showed the
greatest absolute and preferential cytotoxicity in most
cell lines tested (Fig. 1). The data obtained in the currentstudy conﬁrmed the cytotoxic eﬀects of P. harmala seed
extract. In all cell lines tested P. harmala seed extract
had greater cytotoxic eﬀect compared to Spinal-Z (Table
1). However in most cell lines, the cytotoxic indices for
P. harmala seed extract and Spinal-Z were similar
(Fig. 1).
In order to further delineate the preferential cytotoxic
eﬀects of the agents used, the mean IC50 of the agent
against all cell lines was compared with the IC50 value
of the agent against each cell line (Fig. 2). A172,
A278-S and HL60 cell lines exhibited the greatest sensi-
tivity to D. kotschyii extract and the KB cell line was rel-
atively much more sensitive to the D. kotschyii extract
than to the P. harmala extract or Spinal-Z.
IC50 values obtained for harmine, the major b-carbo-
line alkaloid found in P. harmala extract against HL60
and K562 cell lines were found to be 1.7 ± 0.1 and
1.9 ± 0.3 lg/mL, respectively.
In order to evaluate the contribution of D. kotschyii
and P. harmala towards the cytotoxic eﬀects of Spinal-
Z, mixtures of various proportions of the two extracts
were prepared (Table 2) and their cytotoxicity was eval-
uated against HL60 cell line. A mixture containing 60%
D. kotschyii extract showed the smallest IC50 and there-
fore the greatest eﬀectiveness against HL60 cells.2.2. In vivo anti-tumor properties
The anti-tumor activities of the extracts and doxoru-
bicin (DOX) (as positive control) were studied by treat-
ing mice, inoculated with WEHI 164 cells, with the test
mixtures. In cell culture studies the IC50 values for
Spinal-Z, D. kotschyii (DK), and P. harmala (PH)
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Fig. 1. The cytotoxic indices of Spinal-Z (j), Dracocephalum kotschyii leaf extract (h) and Peganum harmala seed extract ( ) on a panel of cell lines.
In all cell lines tested, the cytotoxic index of Dracocephalum kotschyii was statistically diﬀerent from Peganum harmala and Spinal-Z (***p < 0.001,
**p < 0.01).
0
0.5
1
1.5
2
2.5
3
3.5
A172 A2780-s HL60 KB K562 MCF-7 Saos-2 Hela A2780-
cp
A549 A375
Ce
ll 
Li
ne
 IC
50
 / 
M
ea
n 
IC
50
 fo
r a
ll 
Ce
lll
in
es
Fig. 2. Diﬀerential cytotoxic eﬀects of Spinal-Z (j), Dracocephalum kotschyii leaf extract (h) and Peganum harmala seed extract ( ) on a panel of
cell lines. The graph displays the ratio of mean IC50 value of the test compound for the particular cell line and the IC50 value of the test compound
against all cell lines tested.
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76.1 ± 0.14, 26.5 ± 0.16 and 54.2 ± 0.22 lg/mL,
respectively.
The changes in the volume of tumors induced in mice
were calculated (Fig. 3). Compared to the control group,
both DK and DOX groups showed a statistically signif-
icant slower rate of tumor volume growth 12 days afterinoculation. The ﬁnal tumor volume, determined on the
last day, was statistically smaller in both DK and DOX
groups compared to the control group (p < 0.001). In
addition, the tumor volume in animals treated with
DK was smaller than the group receiving DOX after
day 12. This diﬀerence was statistically signiﬁcant
(p < 0.001).
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Fig. 3. Eﬀects of Spinal-Z and its components on solid tumor volumes induced in BALB/c mice. Five groups of six BALB/c mice were injected
subcutaneously with WEHI 164 cells. The animals were injected with (s) Doxorubicin, (d) Dracocephalum kotschyii leaf extract, (h) Spinal-Z, (n)
Peganum harmala seed extract or (j) vehicle. The volume of the tumor was measured every 4 days. Values are means ± SD, n = 6.
Table 2
Eﬀects of Dracocephalum kotschyii content upon the cytotoxicity of in-lab prepared ‘‘Spinal-Z’’ remedy
Spinal-Z Peganum harmala:Dracocephalum kotschyii content (% w/w)
100: 0 0:100 20:80 40:60 50:50 60:40 80:20
IC50 (lg/mL) 66 ± 1 24 ± 2 16.3 ± 2 22.6 ± 2 12.5 ± 1 49.0 ± 3 27.7 ± 2 17 ± 1
IC50 value was calculated by measuring HL60 cell proliferation using the MTT assay and is deﬁned as the drug concentration (lg/mL) causing a 50%
inhibition of cell growth.
Data represent mean values ± SD for three independent experiments.
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ing P. harmala was smaller than the control group, from
day 15, the trend was reversed. The eﬀect of Spinal-Z on
tumor volume resembled the eﬀects of P. harmala.
The weights of tumors after excision (Table 3) were in
agreement with the calculations of the tumor volumes
on day 24.
The changes in mice body weights were recorded
(Fig. 4). Animals receiving D. kotschyii and DOX
started to gain weight from day 7, while the body weight
of control animals or mice receiving Spinal-Z remained
more or less unchanged throughout the treatment. The
animals receiving P. harmala, showed a decrease in body
weight from day 12 onward. The change in body weighton day 24 compared to day 0, was used to calculate
BWL (Table 4). Compared to the control group, the
mice receiving D. kotschyii, Spinal-Z or DOX, showed
a negative BWL, indicating weight gain. The weight gain
in mice receiving Spinal-Z was statistically negligible,
while the weight gain in mice receiving D. kotschyii or
DOX was statistically greater than the control group
(p < 0.001). Animals receiving P. harmala showed a sta-
tistically greater BWL compared to the control group.
In addition, the D/U ratio was highest in the animals
receiving P. harmala and lowest in the mice receiving
D. kotschyii or DOX (Table 4).
Results from histological study of the tumor tissues
after hematoxylin–eosin staining are presented in
Table 4
Eﬀects of Spinal-Z and its constituents on the intensity of the side
eﬀects in and survival of tumor bearing mice
BWL Average life
span
% ILS D/U
Control 0.045 22.7 ± 2.1 – 1/6
Doxorubicin 11.64 25 ± 0.01* 10.06 0/6
Spinal-Z 1.864 23.3 ± 2.1ns 2.73 1/6
Peganum harmala 19.532 18 ± 2.28*** 18.55 4/6
Dracocephalum kotschyii 10.22 25 ± 0.01* 10.06 0/6
Body weight loss (BWL) was calculated as (1  BWn/BWs) · 100
where BWn is the body weight on day n and BWs is the body weight on
day zero.
Increase in life span (ILS) was calculated as T  C/C · 100, where T is
the average number of days the animal in each group survived and C is
the average number of days the animals in control group survived.
D/U: Number of toxic deaths/total number of mice.
ns = not statistically signiﬁcant.
Values are means ± SD, n = 6.
* p < 0.05.
*** p < 0.001.
Table 3
Eﬀects of Spinal-Z and its constituents upon tumor growth in mice
inoculated with WEHI-164 cells
Group The weight of tumor (g)
Control 2.5 ± 0.26
Doxorubicin 1.6 ± 0.47**
Spinal-Z 2.8 ± 0.41ns
Peganum harmala 3.8 ± 0.78**
Dracocephalum kotschyii 1.4 ± 0.34**
Five groups of six BALB/c mice were injected subcutaneously with
WEHI 164 cells. The animals were injected with the plant extract,
doxorubicin or vehicle. On day 24, animals were killed and tumors
were removed and weighed. The weight of tumors for animals in test
groups were compared with those of the control group.
ns = not statistically signiﬁcant.
Values are means ± SD, n = 6.
** p< 0.01.
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between the percent death observed in the tumor tissues
from the DK, PH or Spinal-Z groups while all three
groups were statistically diﬀerent from the control group
(p < 0.001). The ratio of apoptosis to necrosis was high-
est in the DK group and lowest in the DOX group.
2.3. Isolation and identiﬁcation of the active ingredient
The methanolic extract of D. kotschyii was subjected
to TLC. 13 fractions were obtained and tested for cyto-
toxic eﬀects on HL60 cell line. Fraction 10 showed cyto-
toxic eﬀects. This fraction was further puriﬁed using
semi-preparative HPLC which yielded 9 peaks (Fig. 5).
Peak IV, with a retention time of 41 min exhibited cyto-16
17
18
19
20
21
22
23
24
25
0 5 10
D
M
ea
ns
 b
od
y 
w
ie
gh
t (
g)
Fig. 4. Eﬀects of Spinal-Z and its components on body weight of mice in
Doxorubicin, (d) Dracocephalum kotschyii leaf extract, (h) Spinal-Z, (n) Peg
measured every 4 days. Values are means ± SD, n = 6.toxic activity against HL60 cell line. The structure of
peak IV was determined using spectral analysis:
5-Hydroxy-2-(4-hydroxyphenyl)-6,7,8–trimethoxy-4H-
chromene-4-one.
Yellow powder, m.p: 227–230 C, IR (KBr) (mmax,
cm1): 1691 (C@O) Ms, m/z (%): 345 (m+ + 1, 15), 344
(M+, 30), 329 (20), 301 (15), 284 (5), 211 (20). Anal.
Calc. for C18H16O7 (344.8): C, 62.64; H, 4.64; CH30,
26.97%. Found: C, 62.7; H, 4.71; CH3O, 27.07% 1H
NMR (500.1 MHz, CDCl3): d = 3.96, 3.98, and 4.12
(9H, 3 s, 3 OMe), 5.63 (1H, brs, OH), 6.60 (1H, s,
CH), 7.00 (2H, d, 3JHH = 8.4 Hz, CH30 ), 7.85 (2H, d,15 20 25
ays
oculated with WEHI-164 cells. The animals were injected with (s)
anum harmala seed extract or (j) vehicle. The animal body weight was
Table 5
Eﬀect of Spinal-Z and its components on cell death induced in WEHI-
164 solid tumors
Group % Total
cell death
Ratio apoptosis
to necrosis
Control 15 ± 1 0.33 ± 0.1
Doxorubicin 32 ± 1.3 0.48 ± 0.03**
Spinal-Z 58 ± 3.2 0.05 ± 0.01***
Peganum harmala 66 ± 7.1 1.04 ± 0.22***
Dracocephalum kotschyii 60 ± 3.1 1.86 ± 0.20***
Five groups of six BALB/c mice were injected subcutaneously with
WEHI 164 cells. The animals were injected with the plant extract,
doxorubicin or vehicle. On day 24, animals were killed and tumors
were removed and weighed. Tumor tissues were stained using hemot-
oxylin–eosin and examined microscopically for cell death. %Total cell
death and ratio of apoptotic to necrotic cell death for each group were
compared with the control group.
Values are means ± SD, n = 6.
** p < 0.01.
*** p < 0.001.
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Fig. 6. Structure of Xanthomicrol.
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13C NMR
(125.7 MHz, DMSO-d6): d = 60.04, 61.96, and 62.40 (3
OMe), 103.12 (C3), 106.82 (C10), 116.65 ðCH30;50 Þ,
121.50 ðC10 Þ, 128.97 ðCH20;60 Þ, 133.15 (C8), 136.191
(C6), 145.69 (C7), 149.021 (C9), 152.99 (C5), 162.05
ðC40 Þ, 164.8 (C2) and 183.03 (C4).
The trivial name of this compound is xanthomicrol
and the semi-systematic name is 5,4 0-dihydroxy-6,7,8-
trimethoxyﬂavone (Fig. 6) (Stout and Stout, 1961;
Grayer et al., 2001; Jamzad et al., 2003). The cytotoxic-
ity of xanthomicrol obtained from methanolic DK ex-0
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Fig. 5. The HPLC chromatogram of Plate Layer Chromatography fraction
contained the maximum cytotoxic activity against HL 60 cells. Chromatogr
phase: Acetonitrile: 0.05 M HCl (75:25 v:v) pumped at 10 mL/min. Detectiotract was investigated against a panel of cell lines
(Table 6). Xanthomicrol showed a much larger IC50 va-
lue compared to doxorubicin in all cell lines tested.
However, the cytotoxicity index of xanthomicrol against
all cell lines tested was signiﬁcantly greater than doxoru-
bicin (p < 0.001).
The mechanism of the cytotoxic eﬀect of xanthomi-
crol was studied using ﬂuorescent microscopy. Xant-
homicrol induced a concentration dependent total and
apoptotic cell death (Fig. 7). Necrotic cell death induced
by xanthomicrol, however, reached a plateau at a con-
centration of 50 ng/mL. Camptothecin too induced a
concentration dependent total cell death. However at
higher concentrations, the contribution of necrotic cell
death towards total cell death was much greater with
camptothecin than xanthomicrol. Camptothecin was
more eﬀective in inducing total cell death at 100 and
250 ng/mL, while at lower concentrations (12.5 and 50
ng/mL) xanthomicrol produced greater cell death.55 65 75
e (min)
10 of DK methanolic extract. Peak IV with a retention time of 40 min
aphy conditions: Column: Nucleosil 100–10, 25 cm · 16 mm. Mobile
n: 220 nm.
Table 6
The cytotoxic eﬀect of xanthomicrol and doxorubicin against a panel of human cell lines
IC50 (lg/mL) Cytotoxicity index
Xanthomicrol Doxorubicin Xanthomicrol Doxorubicin
HL60 0.88 ± 0.04 0.04 ± 0.02 15.76 0.42
K562 1.69 ± 0.03 0.11 ± 0.05 8.2 0.18
Saos-2 0.75 ± 0.09 0.02 ± 0.01 18.5 1.1
A2780-cp 1.56 ± 0.04 0.06 ± 0.02 8.9 0.32
A2780-s 0.89 ± 0.06 0.06 ± 0.01 15.5 0.32
HFFF-P16 13.8 ± 0.09 0.018 ± 0.01 – –
IC50 value was calculated by measuring cell proliferation using the MTT assay and is deﬁned as the drug concentration (lg/mL) causing a 50%
inhibition of cell growth. Cytotoxicity index was calculated by dividing the IC50 of the test compound against HFFF-P16 cells by the IC50 of the test
compound against the particular cell line.
Data represent mean values ± SD for three independent experiments.
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Fig. 7. Eﬀects of xanthomicrol (s) and camptothecin (d) on apoptotic (A), necrotic (B) and total cell death (C) induced in cultured HL60 cells.
HL60 cells were treated with the drug for 4h and stained immediately with acridine orange and propodium iodide. The stained cells were examined
using ﬂuorescence microscopy. Values are means ± SD, n = 6.
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In this work, the cytotoxic and anti-tumor eﬀects of
Spinal-Z, an Iranian ethnobotanical anti-cancer remedy,
and its constituents were studied. In vitro cell prolifera-
tion inhibition test using MTT viability assay conﬁrmed
that both Spinal-Z and its constituents (the leaf extract
of D. kotschyii and the seed extract of P. harmala) have
cytotoxic activity against all cell lines tested. Compari-
son of the cytotoxic indices (Fig. 1) and diﬀerential cyto-
toxicity (Fig. 2) calculated for Spinal-Z, suggests that
this cytotoxic eﬀect is preferentially exerted against can-
cer cell lines. Both herbal constituents of Spinal-Z
showed cytotoxicity in in vitro tests. The absolute cyto-
toxicity of Spinal-Z against most cell lines tested, resem-
bled the cytotoxicity proﬁle of P. harmala extract more
than the proﬁle obtained with D. kotschyii extract.
Spinal-Z is an extract of 80% w/w P. harmala powdered
seeds and 20% w/w D. kotschyii powdered leaves. It is
thus expected that the eﬀects of Spinal-Z should resem-
ble those of its main component i.e. P. harmala seed ex-
tract. This view is conﬁrmed by strong similarity
between the cytotoxic indices and diﬀerential cytotoxic-
ity of Spinal-Z and P. harmala seed extract.
Our results suggested that D. kotschyii leaf extract is
the more potent constituent of Spinal-Z. Compared to
P. harmala seed extract, D. kotschyii had a smaller
IC50 value against A172, A2780-s, HL60, KB, MCF-7
and Saos-2 cells. Also, D. kotschyii extract was less toxic
towards HFFF-P16 cells compared to P. harmala ex-
tract. The obtained data indicated that a 80:20 w/w mix-
ture of P. harmala:D. kotschyii extracts may not be
optimal. When the cytotoxic eﬀects of mixtures of diﬀer-
ent proportions of P. harmala seed extract and D.
kotschyii leaf extract against HL60 cell line were investi-
gated (Table 2), it was found that a 40:60 w/w mixture of
P. harmala:D. kotschyii extracts had the smallest IC50
value. However, the diﬀerence between the IC50 values
of diﬀerent proportion mixtures was not very large.
An anomaly observed was the 3-fold diﬀerence between
the IC50 values of the 80:20 mixture of P. harmala:D.
kotschyii prepared in the lab and Spinal-Z (commercial
product). During the preparation of Spinal-Z, a mixture
of 80:20 P. harmala seed and D. kotschyii leaf are re-
ﬂuxed together, while in the lab, a mixture of 80% P.
harmal a seed extract and 20% D. kotschyii leaf extract
were prepared. The diﬀerent preparation procedures
might explain the diﬀerence observed between the cyto-
toxic eﬀects of Spinal-Z and the 80:20 mixtures of P.
harmala and D. kotschyii extracts.
P. harmala had previously been shown to have cyto-
toxic eﬀects (Lamchouri et al., 2000). In this work, the
cytotoxic eﬀects of P. harmala on three previously unre-
ported cell lines (K562, HL60, and A172) were demon-
strated. This work also conﬁrmed the idea that
cytotoxic eﬀects of P. harmala seed extract could beattributed to its harmine contents (Sandler et al., 2002).
The in vitro experiments carried out in this study, con-
ﬁrmed the eﬀectiveness of Spinal-Z and its components
as cytotoxic agents against a panel of cell lines. To inves-
tigate the anti-tumor properties of this remedy, eﬀects of
Spinal-Z and its components on tumors induced in
BALB/c mice (using murine ﬁbrosarcoma WEHI-164
cell line) were investigated. In order to determine the
eﬀectiveness of the agent, the volume of tumor was esti-
mated every four days. Also to assess the degree of side-
eﬀects induced by the agent, changes in the body weight
was determined every four days, and in order to show the
overall eﬀectiveness of the treatment, the life spans of the
animals were calculated. After the animals were killed
and the tumors were excised and weighed, the tumor tis-
sue were ﬁxed and stained for microscopic examination.
As a positive control, doxorubicin was used.
The results from in vivo experiments suggest that
compared with the clinically used DOX dose regimen,
D. kotschyii leaf extract was more eﬀective in inhibiting
tumor growth rate. Animals receiving DOX or D.
kotschyii leaf extract showed no loss of body weight,
suggesting minimal toxicity and/or side-eﬀects associ-
ated with the treatment. The average ﬁnal tumor weight
in animals receiving DOX or D. kotschyii leaf extract
was similar and signiﬁcantly smaller than control. Aver-
age life span, increase in span of life and the D/U ratio
was the same for the animals receiving DOX or D.
kotschyii leaf extract.
Animals receiving P. harmala seed extract scored
badly on all criteria. They had a large tumor volume
growth rate, the largest BWL, the shortest span of life
and therefore a negative increase in life span. Also, more
animals in this group died during the experiment than
those belonging to the control group. The animals receiv-
ing Spinal-Z, were only marginally better than the con-
trol group on BWL and average life span. The tumor
volume growth rate in the Spinal-Z group was faster than
the control group during the last few days of the experi-
ment and the ﬁnal tumor weight was larger than the con-
trol, although this was not statistically signiﬁcant.
Microscopic examination of the hemotoxylin–eosin
stained tumor tissues revealed that the total tumor cell
death in animals receiving the leaf extract of D. kotschyii
was higher than the group receiving DOX. Also, the leaf
extract of D. kotschyii produced a much greater ratio of
apoptosis/necrosis than DOX treatment. Although com-
pared to the D. kotschyii group, the absolute cell death
was greater in the P. harmala group; the apoptosis/
necrosis ratio was signiﬁcantly lower in the latter.
The results obtained thus far suggested that: Spinal-Z
and its components (the leaf extract of D. kotschyii and
the seed extract of P. harmala) were cytotoxic. D.
kotschyii leaf extract acted more selectively on the can-
cer cells compared to normal cells, than Spinal-Z or P.
harmala seed extract. From an in vivo point of view,
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anti-tumor remedy than either Spinal-Z or P. harmala
seed extract. This was mainly because the animals
receiving D. kotschyii showed less side-eﬀects (as repre-
sented by BWL and D/U) and slower tumor volume
growth rates than those receiving P. harmala seed
extract or Spinal-Z. Hence, D. kotschyii leaf extract ap-
peared to act eﬀectively and selectively as an anti-tumor
remedy and thus the isolation and identiﬁcation of the
active component would be desirable.
In order to produce suﬃcient amounts of the active
component for spectral identiﬁcation rapidly, a combi-
nation of TLC and HPLC was used. TLC was able to
separated D. kotschyii leaf extract into 13 fractions,
one of which (fraction 10) contained cytotoxic activity.
This fraction was separated into 9 peaks using reverse
phase HPLC. Of the 9 peaks, peak 4 had cytotoxic prop-
erties. This peak was identiﬁed as xanthomicrol.
The cytotoxic eﬀects of xanthomicrol against a num-
ber of cell lines were investigated. Although in all cell
lines tested, xanthomicrol had a much larger IC50 value
than DOX, the cytotoxic index calculated, was much
greater for xanthomicrol than for DOX. Thus one might
conclude that although larger amounts of xanthomicrol
are needed to reach the tumor cells, the compound pro-
duced far less damage to non-malignant cells than DOX
and would probably produce less side-eﬀect. Results
from ﬂuorescent staining of HL60 cells treated with
xanthomicrol suggest that at all concentrations used,
major proportion of cell death induced by this com-
pound is apoptotic. This is in contrast with camptothe-
cin which only at lower concentrations caused apoptotic
cell death and at higher concentrations caused mainly
necrotic cell death.
Xanthomicrol was isolated from Yerba Beuna (Satur-
eja douglasii) by Power and Salway and its structure was
reﬁned Stout and Stout (1961) . Since its ﬁrst isolation,
this ﬂavone has been demonstrated to exist in many dif-
ferent plants including the genus Ocimum (fam. Labia-
tae) (Grayer et al., 2001), Brickellia paniculata (fam.
Compositae) (Meckes et al., 2002) and more recently
in D. kotschyii by Jamzad et al. (2003). Meckes et al
demonstrated that xanthomicrol was able to inhibit ace-
tylcholine, histamine and Ca2+ induced spasms of the
guinea pig ileum (Meckes et al., 2002). They also showed
xanthomicrol to be anti-inﬂammatory (Meckes et al.,
2002).
In the present study, we were able to demonstrate that
xanthomicrol has cytotoxic and anti-tumor eﬀect and is
probably the active ingredient inD. kotschyii leaf extract.4. Conclusion
Spinal-Z and its major component, P. harmala seed
extract, are cytotoxic. But neither appears to be clini-cally valuable anti-tumor agent in mice inoculated with
WEHI-164 cells. D. kotschyii leaf extract, however, is
both preferentially cytotoxic against malignant cells in
vitro and has beneﬁcial eﬀects as an anti-tumor prepara-
tion in mice inoculated with WEHI-164 cells. The cyto-
toxic/anti-tumor component in the D. kotschyii leaf
extract appears to be xanthomicrol. Clearly, further
investigation on the mechanism of action and in vivo
anti-tumor eﬀects of xanthomicrol are needed to demon-
strate whether or not xanthomicrol is likely to be a clin-
ically signiﬁcant anti-tumor agent.5. Experimental
5.1. Materials
RPMI-1640 medium, FBS (Fetal bovine serum),
penicillin, streptomycin, harmine Æ HCl, MTT {3-(4-,5-
dimethylthiazol-2-yl)-2,5-diphenylterrazolium bro-
mide}, dimethylsulfoxide (DMSO), propidium iodide
(PI), acridine orange (AO), hematoxylin, eosin and cam-
ptothecin were obtained from Sigma Chemical Co. (St.
Louis, MO, USA). Cell lines (K562: Human chronic
myeloid leukemia, HL60: Human promyelotic leukemia,
Hela: Human cervix carcinoma, KB: Human oral epi-
thelial carcinoma, A 549: Human lung carcinoma,
Saos-2: Human osteogenic sarcoma, A2780-CP: Human
ovarian carcinoma resistant to cisplatin, A2780-S: Hu-
man ovarian carcinoma sensitive to cispaltin, MCF-7:
Human breast adenocarcinoma, A375: Human malig-
nant melanoma, A172: Human glioblastoma, and
HFFF-P16: Human fetal foreskin ﬁbroblast) were ob-
tained from Pasteur institute, Tehran, Iran. Commercial
Spinal-Z remedy was a gift from Darou Pakhsh Phar-
maceutical Company and contained the dried methan-
olic extract of an 80:20 mixture of dried powdered
seeds of P. harmala and leaves of D. kotschyii. Doxoru-
bicin was obtained from TEMAD pharmaceutical com-
pany, Tehran, Iran.
5.2. Animals
Male 6-week-old BALB/c mice were purchased from
Pasteur Institute (Tehran, Iran). The animals were kept
6 in a cage and had free access to food pellets and water.
All procedures involving animals were approved by and
carried out under the supervision of the Razi Institutes
Ethic Committee.
5.3. Preparation of plant material
5.3.1. Preparation of P. harmala and D. kotschyii
methanolic extracts
The leaves of D. kotschyii and seeds of P. harmala
were collected from Esfahan and Tehran provinces,
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herbarium at the school of pharmacy, Tehran Univer-
sity. Voucher specimens of P. harmala (6536 TEH)
and D. kotschyii (6537 TEH) have been deposited in
the Herbarium of Department of Pharmacognosy,
School of Pharmacy, University of Tehran.
Hundred grams of dried pulverized plant material
(leaves of D. kotschyii or seeds of P. harmala) were re-
ﬂuxed with 300 mL methanol for 1h. The suspension
was ﬁltered. The resulting extract was dried in vacuo
and stored at 80 C until needed.
5.3.2. Isolation and puriﬁcation of the active component in
D. kotschyii leaf extract
In order to purify the active ingredient of D.
kotschyii, a combination of preparative TLC and HPLC
were used. After fractionation of the methanolic extract
by TLC, the most active fraction was subjected to semi
preparative HPLC analysis as described below. Hun-
dred and ﬁfty milligrams of methanolic D. kotschyii ex-
tract was dissolved in 5 mL Methanol. The solution was
applied to a silica coated glass plate (20 cm · 20 cm) as a
strip, 2 cm from the plate edge. The plate was developed
in a TLC tank using chloroform: methanol: 14 M
NH4OH (15:4:1). Thirteen bands were separated on
the plate. Each band was scraped oﬀ the plate and the
components were eluted from silica using 100 mL meth-
anol. The 13 methanolic fractions obtained were dried in
vacuo and dissolved in DMSO for subsequent MTT
assay.
In order to obtain enough material for subsequent
HLPC puriﬁcation and spectral analysis, 15 g of D.
kotschyii methanolic extract were fractionated as de-
scribed above. Hundred milligrams of fraction 10 from
TLC analysis (Rf = 0.69) was dissolved in 10 mL mobile
phase. To remove particulate matter, the mixture was
centrifuged at 20000g for 10 min. The clear supernatant
was subjected to semi-preparative HPLC. The chro-
matographic system comprised of: Two Wellchrom
Knaur k-1001 HPLC Pumps, a Linear 200 UVIS UV/
Visible detector and a Macherey-Nagel Ecoprep HPLC
column (Nucleosil 100-10, 25 cm · 16 mm). Mobile
phase Acetonitrile: 0.05 M HCl (75:25) was pumped at
10 mL/min (each pump set at 5 mL/min). Detection
was at 220 nm. 0.4 mL sample was loaded into the col-
umn during each run. Peaks were collected, dried in va-
cuo and assayed for cytotoxic eﬀects. The HPLC
puriﬁcation was repeated to obtain about 15 mg of each
puriﬁed compound. The structure of the puriﬁed com-
pound with highest cytotoxic activity was determined
using spectral analysis.
5.3.3. Preparation of test solutions for in vitro
cytotoxicity assay
Spinal-Z, the in-house prepared P. harmala seed or D.
kotschyii leaf extracts were dissolved in DMSO at a con-centration of 200 mg/mL. After ﬁltration through a 0.2
lm Poraﬁl ﬁlter (Macherey-Nagel GmbH & Co. KG
Germany), the solutions were diluted to the desired con-
centrations using RPMI-1640 medium.
For the study of the combinational eﬀects of the two
plant extracts, 200 mg/mL ﬁltered stock solutions were
combined to yield 80:20, 60:40, 50:50, 40:60 and 20:80
mixtures of P. harmala seed and D. kotschyii leaf
extracts.
Harmine was dissolved in DMSO at 1 mg/mL. 1 mg
of TLC fraction was dissolved in 1 mL DMSO. The
solution was ﬁltered through a 0.2 lm Poraﬁl ﬁlter
and diluted to the required concentration using RPMI-
1640 medium.
1 mg puriﬁed compound obtained from semi-prepara-
tive HPLC was dissolved in 1 mL DMSO and diluted to
the required concentrations using RPMI-1640 medium.
5.4. In vitro cytotoxicity assay
5.4.1. MTT assay
MTT assay (Mosmann, 1983) was used to measure
cytotoxicity of Spinal-Z and its components. Each cell
line was maintained and treated in suspension in
RPMI-1640 medium supplemented with 10% FBS, 50
units/mL penicillin and 50 lg/mL streptomycin. Cells
were grown under an atmosphere of 5% CO2/95% air
at 37 C. These cells were then plated in 96 well plates
(5 · 103 cells/well) and incubated under 5% CO2/95%
air at 37 C for 24 h. The cells were treated with the test
compounds for 72 h. After addition of MTT (10 lL/
well, 5 mg/mL in phosphate-buﬀered saline), the plates
were incubated for 4 h under 5% CO2/95% air at 37
C. Oxidized dye was dissolved by addition of 100 lL
DMSO per well. The absorbance was measured at 570
nm using a Dynex MRX micro plate reader.
5.4.2. Fluorescence staining
HL60 cell line was maintained and treated in suspen-
sion in RPMI-1640 medium supplemented with 10%
FBS, 50 units/mL penicillin and 50 lg/mL streptomycin.
Cells were grown under an atmosphere of 5% CO2/95%
air at 37 C. Cells were plated in 6 well plates (1 · 106
cells/well) and incubated under 5% CO2/95% air at 37
C for 24 h. Cells were treated with the test compound
or camptothecin, both dissolved in DMSO, for 4 h. A
manual apoptosis assay was performed by using a dual
staining solution containing 10 lg/mL acridine orange
(AO, Sigma) and 50 lg/mL propidium iodide (PI,
Sigma) in phosphate buﬀered saline (PBS) (Simpson
et al., 1999). A 100 lL volume of HL60 cell suspension
was mixed 1:1 with the dual staining solution. The
resulting mixture was loaded onto a glass slide and
examined immediately at 200· magniﬁcation, using an
Olympus IX-71 inverted ﬂuorescence microscope
equipped with a U-MWB2 ﬂuorescence mirror unit.
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Top, middle and bottom regions of slide, each contain-
ing 100 cells, gave a total of 300 counted cells per sam-
pling point. Viability results are presented as a
percentage of the total number of cells counted. No at-
tempts were made to distinguish between late and early
apoptotic cells. Cells were categorized into groups by
virtue of their color and chromatin morphology. Green
cells with dispersed chromatin were designated as viable.
Green cells with condensed chromatin or red cells with
condensed chromatin fell into the apoptotic category,
while those red cells with dispersed chromatin were des-
ignated to be necrotic.
5.4.3. In vivo anti-tumor assay
Five groups of six BALB/c mice were injected sub-
cutaneously in the right ﬂank with 1.5 · 106 WEHI
164 ﬁbrosarcoma cells (Wilson et al., 1989). One day
later mice were injected intraperitoneally, everyday
for 3 weeks, with 30 lL of DMSO (Control group),
30 lL 30 mg/kg Spinal-Z (SZ group), 30 lL 6 mg/kg
D. kotschyii leaf extract (DK group), or 30 lL 24
mg/kg P.harmala seed extracts (PH group). The mice
in the last group (DOX group) were injected with 30
lL 2 mg/kg doxorubicin on days 3 and 17 after subcu-
taneous inﬁltration of WEHI 164 cells (Wilson et al.,
1989). At four day intervals, the animals were weighed
and the tumor size was estimated by measuring the
diameters of the elliptical tumors in two perpendicular
dimensions using vernier calipers. The volume of tumor
was calculated using the formula: 4pr21r2=3, where r1
and r2 were the short and long tumor radii, respectively
(Rajeshkumar et al., 2002). In order to evaluate inten-
sity of the side-eﬀects of the treatment, body weight
loss (BWL) and the ratio of animals which died during
the course of experiment to the number of animals
used (D/U) in the test were determined (Kumazawa
et al., 1998). BWL was calculated as (1  BWn/
BWs) · 100, where BWn is the body weight at day n
and BWs is the body weight at day zero. Increase in
life span (ILS) was calculated as T  C/C · 100, where
T is the average number of days the animal in each
group survived and C is the average number of days
the animals in control group survived (Kruczynski
et al., 1998; Kumazawa et al., 1998).
On day 24, the animals were killed by cervical dislo-
cation and tumors were removed and weighed. The ex-
cised tissues were ﬁxed in 10% formalin for 24 h and
subsequently embedded in paraﬃn. Five micrometer
sections were prepared and stained by standard hema-
toxylin–eosin method (Will et al., 1994). The sections
were studied microscopically for the presence of dense
chromatin bodies – representative of apoptosis and
occurrence of necrotic cell death. The pathologist exam-
ining the sections was unaware of the animal group each
section belonged to.Acknowledgments
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